Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Virpax Pharmaceuticals, Inc. (VRPX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-KS-1S-1S-1/A
OPERATING EXPENSES       
General and administrative  11.17.22.92.61.5
Research and development  10.84.81.30.61.1
    Total operating expenses  44.425.54.23.22.6
    Loss from operations  -21.8-12.0-4.2-3.2-2.6
   
OTHER INCOME       
Other income  0.2-0.10.10.10.0
    Loss before tax provision  -21.7-12.1-4.3-3.3 
   
Income taxes       
    Net loss  -21.7-12.1-4.3-3.3-2.6
   
Basic and diluted net loss per share (in Dollars per share)  ($1.85)($1.81)($1.40)($1.13)($0.93)
   
Basic and diluted weighted average common stock outstanding (in Shares)  11.76.73.12.92.8

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy